54257-88-4 Usage
Chemical structure
2-(4-Benzylpiperazino)-N-(4-chlorophenyl)acetamide consists of a complex structure with a piperazine ring, a benzyl group, and a chlorophenyl group.
Potential pharmaceutical applications
The compound has potential activity as a protein kinase inhibitor, which is an enzyme that regulates various cellular processes.
Treatment potential
Inhibitors of protein kinases have the potential to be used in the treatment of cancer and other diseases.
Biological activity
The presence of the benzyl and chlorophenyl groups in the compound may contribute to its biological activity.
Interest for further study
Due to its structure and potential biological activity, 2-(4-Benzylpiperazino)-N-(4-chlorophenyl)acetamide is a compound of interest for further research and potential drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 54257-88-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,4,2,5 and 7 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 54257-88:
(7*5)+(6*4)+(5*2)+(4*5)+(3*7)+(2*8)+(1*8)=134
134 % 10 = 4
So 54257-88-4 is a valid CAS Registry Number.
54257-88-4Relevant articles and documents
The design and synthesis of 1,4-substituted piperazine derivatives as triple reuptake inhibitors
Han, Minsoo,Han, Younghue,Song, Chiman,Hahn, Hoh-Gyu
, p. 2597 - 2602 (2012/10/29)
Novel 1,4-substituted piperazine derivatives 5, Series A and B were designed by fragment analysis and molecular modification of 4 selected piperazine-containing compounds which possess antidepressant activity. We synthesized new 39 analogues of Series A and 10 compounds of Series B, respectively. The antidepressant screening against DA, NE, and serotonin neurotransmitter uptake inhibition was carried out using the Neurotransmitter Transporter Uptake Assay Kit. The compounds in Series B showed relatively higher reuptake inhibitory activity for SERT, NET, and DAT than those in Series A. The length of spacer between the central piperazine core and the terminal phenyl ring substituted at the piperazine ring in Series B seems to exert an important role in the activity.